Driving growth, share and profits in the Pharmaceutical industry

Pharmaceuticals

The Forrester Wave™: Marketing Measurement and Optimization, Q3 2023. LEARN MORE
The 2024 Gartner® Magic Quadrant™ for Marketing Mix Modeling Solutions. LEARN MORE

Gartner Leader 2024
solution-forester

The Forrester Wave™: Marketing Measurement and Optimization, Q3 2023. LEARN MORE

solution-forester
Gartner Leader 2024

The 2024 Gartner® Magic Quadrant™ for Marketing Mix Modeling Solutions. LEARN MORE

Helping leading pharmaceutical companies leverage powerful combinations of data and analytics to maximize the impact of their Market Engagement investments

 

The changing pharmaceutical marketing landscape is having a big impact on the promotion strategies of pharmaceutical companies. While personal sales channels (sales force call activity) still dominate investments, the use of non-personal channels has increased substantially. These additional channels serve as a supplement to personal sales as well as to fill the gap created by the physician access challenge. At the same time, increased emphasis on direct to consumer promotions and proliferation of digital and social channels in the promotion mix have created new communication opportunities but also added to executional complexity. In this scenario, it has become more important than ever to understand how these promotional channels interact with each other in driving demand and business growth.

Ipsos MMA’s Pharma marketing effectiveness service focuses companies on how to optimize existing Patient/Caregiver marketing, HCP marketing, salesforce and operational investments, while at the same time identifying where the ‘next dollar’ can be best invested to drive maximum growth and profits.

MMA has been modeling in Life Sciences area for 15+ years

  • Commercial Effectiveness/Marketing Mix Modeling
    • Portfolio optimization, brand optimization
    • Physician-level modeling and district level call optimization
  • Sequencing and Next Best Action
  • Commercial Launch Forecasting
  • Forecasting
  • Commercial analytics data store development and automation
Pharma Marketing Mix Case Study

Optimizing and Billions of Investment Dollars to Drive Millions in Incremental Value for Pharmaceutical Companies

MMA’s powerful and granular modeling approach for financial services allows us to deliver high-value insights by product, customer segment and market to enable teams to pinpoint the marketing investments that yield the greatest ROI. Our semi-automated modeling platform allows us to process and deliver thousands of models in an expedited manner. The result is insights delivered in a timely manner to drive ongoing decision making, monitoring and course-correction throughout the year.

Commercial Effectiveness for pharmaceutical companies leverages large and diverse data sets to create predictive investment scenarios that enable executives to optimize patient/caregiver marketing, HCP marketing, salesforce, and operational investments in core disease states and across indications:

  • Analgesics
  • Antibiotics
  • Arthritis
  • Autoimmune
  • Cardiovascular
  • COPD
  • Diabetes
  • Eye care/contact lenses
  • HIV
  • Hypertension
  • Insomnia/Hypnotics
  • Medical Imaging
  • Migraine
  • Neuroscience
  • Oncology
  • Rheumatic
  • Statins

Tackling the Tough Business Questions

01

What is the value and ROI of my Patient/Caregiver and HCP marketing vehicles and integrated campaigns?

02

How much to invest in DTC vs. HCP? How can I optimize investments to drive physician acquisition, NBRx, RRx and TRx by physician segment & geography?

03

How to take advantage of cross-media interactions? Synergies of salesforce with MCM and Speaker Programs?

04

How to optimize sequencing of promotional activities to achieve expected business outcome?

05

What is the optimal allocation of investment across my portfolio of brands?

06

What is the impact of external factors (competition, formulary, Obama Care, PR, health news, etc.) on business performance?

07

How can I maximize the effectiveness of my new product launches? What is the optimal investment needed to support the forecast?

08

How do I measure the short and long term impact of my investments?

Client Successes

Quantifying Long-term Brand Impact

“Quantifying the long-term impact of marketing with confidence enabled us to build a growth strategy that the entire organization could commit to. When your CFO, President, sales teams, and external partners are working from forecasts they can depend on, you can move faster and commit bigger than competitors still debating internally about where to invest.”

Dan Kleinman | Chief Brand Officer, Josh Cellars

Improve Business Performance through Marketing ROI Optimization

“Unified Marketing Measurement is a critical capability within the automotive industry for OEMs to capture the complex and diverse array of business drivers, including marketing, incentives, operations, economic, competition and consumer, to enable accurate measurement of incremental sales across our portfolio brands. This solution provides predictive actions that we can implement, track, and validate against true business impact.”

Jon Francis | Former Chief Data & Analytics Officer, General Motors

Measured Marketing Effectiveness in a Holistic, Accurate and Globally Manner

Marketing is rightly being held more accountable for true business outcomes across both the short and long term, and that involves connecting multiple complex and siloed datasets for truly holistic analytics. Doing so has allowed us to budget more effectively, forecast future outcomes and track true marketing effectiveness in order to optimize our investment choices across markets, campaign types and channels.

Andy Pilkington |  Global Head of Planning, Media & Analytics, Volvo

Accelerated Profitable Brand Growth at McCormick

Ipsos-MMA consistently delivers robust measurement that enables us to build better media plans that drive higher ROIs, expand measurement in critical areas such as retail media and other emerging tactics, and has provided the support needed to increase media investment and drive business results.

Ramesh Moorthy | Global Strategic Growth Management, Senior Director, McCormick

Empowered Cross-functional Teams to Optimize Commercial Investments

By connecting diverse data and analytics to provide a common foundation for insights, we are empowering cross-functional teams to optimize commercial investments in a synergistic manner, predict future outcomes and continuously track, validate and recalibrate plans using faster, more accurate and more holistic analytic results reflecting the latest consumer, market and business dynamics.

Arvind Balasundaram | Executive Director, Commercial Insights & Analytics, Regeneron

How Nationwide Modernized Its Marketing Mix Model

Because brand health is so integrated with our unified measurement program, we can also show how changes in brand health metrics impact business performance, which is a beautiful thing.

Jamie Byrum | AVP of Marketing Data, Analytics, and Research, Nationwide

Prudential Turned Marketing Measurement into Real Impact

Marketing changed the paradigm so that they are not viewed as a cost. It never should be. It should always be viewed as a very powerful investment, as part of our growth journey.

Caroline Feeney | Global Head of Retirement and Insurance, Prudential Financial

Maximizing ROI Through Unified Measurement

In collaboration with Meta and Ipsos MMA, we were able to leverage advanced MMM solutions to uncover unprecedented insights into our Meta strategies. This innovative approach empowered us to maximize our Meta ROI through optimizing budget allocation across the entire funnel, strengthening our brand campaigns and elevating creative quality and messaging. This partnership has not only informed our strategic direction, but also strengthened our data-driven decision-making culture at Volvo.

Paul Appelqvist | Global Head of Media Execution, Volvo Cars

marketing mix modeling in pharma

Pharma Brand Marketing

Marketing Mix Modeling in Pharma: At the Intersection of Strategic & Executable Insights

Read Article
Pharma Marketing Covid 19

Case Study: Pharma

This client reaped the benefits of Ipsos MMA’s Unified Measurement, combined with HealthVerity’s data management.

Download
Pharma Marketing Analytics

Pharma Marketing Analytics

Unleashing the Power of Pharma Marketing Analytics for Successful Campaigns

 

Read Article

Case Study: Global Pharmaceutical Company

Client Challenge:

The Company was seeking to optimize its multi-billion dollar salesforce, marketing and operations budget supporting a portfolio of four (4) brands in order to drive improved revenues and operating profits. Each brand was at a different stage in its lifecycle. Company executives were seeking to determine and quantify the impact of key business drivers of NBRx, RRx and Physician Acquisition in order to re-allocate investments to achieve target financial objectives.

MMA Solution:

MMA worked with the Company to collect the data and build physician-level statistical models that quantified the historical and projected future impact of growth drivers of NBRx and RRx for each brand and across the portfolio. The granular detail of the results enabled fact-based decision making at the territory, sales area, DMA and national level across brands and by business objective and physician segment.

Results:Pharma Marketing Case Study

The Company took steps to optimize Commercial Investments (salesforce, DTC media, HCP marketing) consistent with the recommendations. Significant re-allocations were made within specific commercial tactics shifting funds from oversaturated and underperforming activities to those with higher ROI potential. Following the first year the Company saw improvements in operating profits of over $110, 000, 000 within the portfolio. It is projected the impact of the ongoing program will produce over $400, 000, 000 in incremental profits over a three (3) year period.

Organizational Beneficiaries

  • Sales Force: Enable pharmaceutical companies to understand optimal size, call frequency, targeting and next best action across geographies and support them with the most effective campaigns and promotional tactics.
  • Portfolio General Managers: Optimize sales, marketing, product and operational investments to support the concept of where “my next dollar should be invested” in order to maximize revenues, profits and share.
  • Marketing/Media: Understand what the key marketing drivers are, their past and projected ROIs, what works, what doesn’t, and when, where and how tactics and strategies can be optimized and deliver higher value in the future.
  • Finance: Gain a better understanding of how to implement and measure cost-effective and efficient marketing plans to drive growth and profitability.
  • Logistics and Forecasting: Understand the impact of operational and non-marketing factors in driving profitable growth. Leverage improved predictability of results to better optimize all business drivers.

Deliverables:

  • Value Proposition & Roadmap – A path to value from the process that supports the organization recognizing, understanding and implementing the results in order to unlock and achieve incremental value from the initiative
  • Improved Financial Results – Support in implementing the results to achieve higher revenue, profits and/or share, depending upon Company objectives.
  • Simulation & Optimization Software and Scenario Planning Tools – Real-time simulation/“what if” scenario planning and marketing budget optimization capabilities.
  • Historical “Due To’s” – Ability to attribute why, how and where the business grew or declined as a result of specific marketing, media, promotion, operational, competitive, economic and other relevant variables.
  • Predictive Stats-based Models – Custom client models are created to understand what happened as well as what will happen when, where and how due to specific market and marketing activities.
  • Data Management Platform – “Big Marketing Data” is collected, cleansed and harmonized to support the analytics as well as client and tracking needs.
  • Expert Consultants – Senior consultants support integration of analytics into client business process to drive usage, value, assimilation and transformation.

See a preview of our marketing performance software suite for the life sciences industry in action